Gschwantler-Kaulich, Daphne <br/><br/>
HER Specific TKIs Exert Their Antineoplastic Effects on Breast Cancer Cell Lines through the Involvement of STAT5 and JNK.  [electronic resource] 

 -  PloS one  2016 
 - e0146311 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0146311  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Afatinib<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Drug Resistance, Neoplasm<br/>Drug Screening Assays, Antitumor<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Humans<br/>Inhibitory Concentration 50<br/>JNK Mitogen-Activated Protein Kinases--metabolism<br/>Lapatinib<br/>MAP Kinase Signaling System<br/>Morpholines--pharmacology<br/>Phosphorylation<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Processing, Post-Translational<br/>Quinazolines--pharmacology<br/>STAT5 Transcription Factor--metabolism